Martin Berducci1,2, Hans F Fuchs3,4, Pablo Omelanczuk2, Ryan C Broderick1, Cristina R Harnsberger1, Joshua Langert1, Jorge Nefa2, Pablo Jaureguiberry2, Pablo Gomez2, Laura Miranda2, Garth R Jacobsen1, Bryan J Sandler1,5, Santiago Horgan1. 1. Division of Minimally Invasive Surgery, Department of Surgery, Center for the Future of Surgery, University of California, San Diego, 9500 Gilman Drive, MC 0740, La Jolla, CA, 92093-0740, USA. 2. Hospital Italiano de Mendoza, Mendoza, Argentina. 3. Division of Minimally Invasive Surgery, Department of Surgery, Center for the Future of Surgery, University of California, San Diego, 9500 Gilman Drive, MC 0740, La Jolla, CA, 92093-0740, USA. hans-fuchs@freenet.de. 4. Department of Surgery, University of Cologne, Cologne, Germany. hans-fuchs@freenet.de. 5. VA Healthcare, San Diego, San Diego, CA, USA.
Abstract
BACKGROUND: Single-incision minimally invasive surgery has previously been associated with incisions 2.0-3.0 cm in length. We present a novel single-incision surgical platform compatible for insertion through a standard 15-mm trocar we previously described in six patients with short-term follow-up data. The objective of this phase II study was to evaluate the safety and feasibility of the platform in a larger collective and to evaluate 1-year follow-up data of the phase I trial. METHODS: The technology features a multiple-use introducer, accommodating the articulating instruments, and is inserted through a 15-mm laparoscopic trocar. Cholecystectomy is performed through an umbilical incision. A prospective feasibility study was performed at a single center. Inclusion criteria were age of 18-75 years and biliary colic, exclusion criteria were acute cholecystitis, dilation of the biliary tree, severe coagulopathy, BMI > 40 kg/m(2), or choledocholithiasis. Endpoints included complications, length of stay, pain medication, cosmetic results, and the presence of hernia. RESULTS: Twenty-seven patients (23 females; phase I: 6 patients, phase II: 21 patients) with an average age of 41.7 years and BMI 26.6 kg/m(2) were recruited for the study. Umbilical incision length did not exceed 15 mm. There were no intraoperative complications. Average OR time decreased from 91 min for the first six cases to 56 min for the last six cases. Average length of stay was 7.8 h. Pain control was achieved with diclofenac for no more than 7 days. All patients had no adverse events at 5-month follow-up, and all phase I patients had no adverse events nor evidence of umbilical hernia at 1 year. CONCLUSION: This study demonstrates that single-incision cholecystectomy with the platform is feasible, safe, and reproducible in a larger patient population. Long-term follow-up showed no hernias or other adverse events. Further studies will be needed to evaluate longer-term hernia rates.
BACKGROUND: Single-incision minimally invasive surgery has previously been associated with incisions 2.0-3.0 cm in length. We present a novel single-incision surgical platform compatible for insertion through a standard 15-mm trocar we previously described in six patients with short-term follow-up data. The objective of this phase II study was to evaluate the safety and feasibility of the platform in a larger collective and to evaluate 1-year follow-up data of the phase I trial. METHODS: The technology features a multiple-use introducer, accommodating the articulating instruments, and is inserted through a 15-mm laparoscopic trocar. Cholecystectomy is performed through an umbilical incision. A prospective feasibility study was performed at a single center. Inclusion criteria were age of 18-75 years and biliary colic, exclusion criteria were acute cholecystitis, dilation of the biliary tree, severe coagulopathy, BMI > 40 kg/m(2), or choledocholithiasis. Endpoints included complications, length of stay, pain medication, cosmetic results, and the presence of hernia. RESULTS: Twenty-seven patients (23 females; phase I: 6 patients, phase II: 21 patients) with an average age of 41.7 years and BMI 26.6 kg/m(2) were recruited for the study. Umbilical incision length did not exceed 15 mm. There were no intraoperative complications. Average OR time decreased from 91 min for the first six cases to 56 min for the last six cases. Average length of stay was 7.8 h. Pain control was achieved with diclofenac for no more than 7 days. All patients had no adverse events at 5-month follow-up, and all phase I patients had no adverse events nor evidence of umbilical hernia at 1 year. CONCLUSION: This study demonstrates that single-incision cholecystectomy with the platform is feasible, safe, and reproducible in a larger patient population. Long-term follow-up showed no hernias or other adverse events. Further studies will be needed to evaluate longer-term hernia rates.
Entities:
Keywords:
Cholecystectomy; Laparoscopic cholecystectomy; Minimal access surgery; Minimally invasive surgery; New technology; Single-site surgery
Authors: Anthony Michael Gonzalez; Jorge Rafael Rabaza; Charan Donkor; Rey Jesús Romero; Radomir Kosanovic; Juan Carlos Verdeja Journal: Surg Endosc Date: 2013-08-13 Impact factor: 4.584
Authors: Sheetal Nijhawan; Juan S Barajas-Gamboa; Saniea Majid; Garth R Jacobsen; Michael F Sedrak; Bryan J Sandler; Mark A Talamini; Santiago Horgan Journal: Surg Endosc Date: 2012-07-18 Impact factor: 4.584
Authors: Ryan C Broderick; Pablo Omelanczuk; Cristina R Harnsberger; Hans F Fuchs; Martin Berducci; Jorge Nefa; Javier Nicolia; Moneer Almadani; Garth R Jacobsen; Bryan J Sandler; Santiago Horgan Journal: Surg Endosc Date: 2014-08-23 Impact factor: 4.584
Authors: Elisabeth C McLemore; Lynn A Weston; Alisa M Coker; Garth R Jacobsen; Mark A Talamini; Santiago Horgan; Sonia L Ramamoorthy Journal: Am J Surg Date: 2014-04-01 Impact factor: 2.565
Authors: Rabi R Datta; Georg Dieplinger; Roger Wahba; Robert Kleinert; Michael Thomas; Florian Gebauer; Lars Schiffmann; Dirk L Stippel; Christiane J Bruns; Hans F Fuchs Journal: Surg Endosc Date: 2019-10-28 Impact factor: 4.584
Authors: Alexander Urbanski; Benjamin Babic; Wolfgang Schröder; Lars Schiffmann; Dolores T Müller; Christiane J Bruns; Hans F Fuchs Journal: Chirurg Date: 2021-02 Impact factor: 0.955